TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Clover Corporation Limited ( (AU:CLV) ) just unveiled an announcement.
Clover Corporation Limited reported a strong financial year in FY25, marked by a significant increase in sales and improved financial performance due to a successful diversification strategy. The company achieved notable milestones, including the commissioning of a fish oil extraction facility in Ecuador and the first full year of profit at Melody Dairies. The company is poised for further growth through its new distributor model and the promising CholineXcel project, targeting infant and prenatal nutrition markets, while continuing to explore opportunities in high-value nutraceutical markets.
The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
More about Clover Corporation Limited
Clover Corporation Limited operates in the nutraceutical and human nutrition industry, focusing on the production of high-quality oils and innovative encapsulated powders. The company is involved in the extraction and refinement of fish oils and other nutritional products, with a market focus that spans North America, Asia, and Europe.
Average Trading Volume: 169,075
Technical Sentiment Signal: Hold
Current Market Cap: A$112.7M
See more data about CLV stock on TipRanks’ Stock Analysis page.